Arterial Occlusive Diseases  >>  roflumilast  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
roflumilast / Generic mfg.
ELASTIC, NCT01630200 / 2011-004152-19: Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)

Completed
4
80
Europe
Roflumilast, Daxas, Placebo
LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology, Medical University of Vienna
Chronic Obstructive Pulmonary Disease and Allied Conditions
01/16
01/16

Download Options